significant reduction in mean pulmonary artery pressure from I8 8 mmHg to I3 I mmHg, right ventricular end-diastolic pressure from i 8 mmHg to o*i mmHg, and left ventricular end-diastolic pressure from 8 2 mmHg to I -9 mmHg. The mean brachial artery pressure, cardiac index, and pulmonary vascular resistance were essentially unchanged. It is concluded that the haenodynamic response of the patients to phentolamine cannot be explained by a single mechanism. Multiple actions of the drug must be considered, including active pulmonary vasodilatation, and a positive inotropic action upon the heart. The administration of phentolamine at an infusion rate of 0o3 mg/min to patients in congestive heart failure produces a striking haemodynamic improvement. The cardiac output, cardiac rate, systemic pressure, and stroke index increase while the pulmonary artery pressure, systemic peripheral resistance, left ventricular end-diastolic pressure, and left ventricular end-diastolic volume fall (Gould, Zahir, and Ettinger, I969) . Further, this conspicuous improvement of cardiac dynamics occurs within minutes, and is not associated with any untoward side effects. Taylor et al. (I965a) studied the pulmonary circulation in normal and hypertensive patients before and after the acute intravenous injection of 5 mg phentolamine. The drug caused a prompt reduction in the right atrial, pulmonary arterial, systemic arterial, and wedge pressures. The cardiac output was invariably increased while the pulmonary vascular resistance was decreased. They concluded that the predominant vascular activity of the drug was to cause a direct relaxation of the vascular smooth muscle, affecting not only the systemic resistance vessels but also the pulmonary and systemic venous circulation.
Phentolamine has an antispasmodic action in the isolated guinea-pig lung (Wisniewska, I964). In addition, it has recently been shown Received 3 July 1970.
that a significant improvement in pulmonary function tests occurs in normal man, as well as in patients with pulmonary emphysema, when a nebulizer containing 5 mg phentolamine in i ml water is used (Gould and Dilieto, I970) .
These observations led us to consider the use of phentolamine in chronic pulmonary disease. We now report the effects of an intravenous infusion of phentolamine in patients with chronic obstructive pulmonary disease without cor pulmonale.
Patients and method
Ten patients with chronic bronchitis or obstructive pulmonary emphysema, or both, without complicating cor pulmonale were studied. All patients had normal heart size on radiological examination and normal electrocardiograms. There was no clinical evidence of coronary or valvular heart disease and none had diastolic hypertension. Their physical characteristics and pulmonary function tests are shown in Table i . All patients were able to lie supine with one pillow for the 2+-hour study period, and none was in acute respiratory distress. Studies were performed in the fasting, post-absorptive state without premedication.
Catheterization of the left ventricle was performed by retrograde arterial catheterization through a brachial arteriotomy. A Cournand (dynes -sec -cm 5); BAm = mean brachial artery pressure (mmHg); CO = cardiac output (ml/sec); PVR = pulmonary vascular resistance (dynes -sec -cm 5); PAm = mean pulmonary artery pressure (mmHg); I-36 = conversion factor from mmHg to cm water; I-050 = whole blood specific gravity. The statistical significance of the differences (P values) between the control values and phentolamine values was calculated with the Student t test.
Five of the catheterized patients subsequently received phentolamine at an infusion rate of 0o3 mg/minute for I5 minutes. This was performed in order to measure the vital capacity, maximum voluntary ventilation, and the one second forced expiratory volume before and after phentolamine.
Results
Complete data on all I0 patients are presented in Table 2 . A summary and statistical analysis of the various parameters during the control period and during the phentolamine infusion are included in this The cardiac index, stroke index, heart rate, oxygen consumption, and arteriovenous oxygen difference did not reveal any significant change during the phentolamine infusion.
The average calculated total peripheral resistance and pulmonary vascular resistance fell minimally during the infusion. The average left ventricular stroke work increased while the average right ventricular stroke work decreased during the infusion. The changes were not statistically significant.
During the administration of phentolamine the minute ventilation increased significantly from 5.34 to 6-66 1./min per m2 (P <o o5). There was no significant change in the arterial blood pH or in the average arterial oxygen saturation. The oxygen and carbon dioxide tension in arterial blood also showed minimal changes.
The pulmonary function studies showed little change after the administration of phentolamine.
Discussion
All the patients studied had clinical evidence of chronic obstructive pulmonary disease. The pulmonary function tests showed variable degrees of impairment though all the patients showed moderate to severe impairment of the maximum voluntary ventilation.
All the patients studied had essentially normal haemodynamic findings before phentolamine administration, so that any directly measured changes produced by the drug must of necessity be small. Moreover, derived data suffer from compounding such small changes. During the infusion of phentolamine there was a significant reduction in the filling pressures of both ventricles and the mean pressures in the pulmonary artery. There was no appreciable change in the cardiac index or systemic arterial pressure. These haemodynamic changes can probably be explained by the recently described inotropic action of the drug.
The administration of 5 mg phentolamine intravenously to normal dogs, each with a strain gauge arch attached to the right ventricle, will increase the ventricular contractile force (Gould et al., I969) . This positive inotropic response in animals has also been seen in humans by employing the left ventricular dp/dt (Gould et At the height of alpha-receptor blockade, the conversion of a tracer dose of tyrosine-14C to norepinephrine in the heart, brain, and adrenal gland was increased threefold with no alteration in specific activity of tyrosine in blood and tissues. From these studies, Dairman concluded that receptor blockade led to increased synthesis and release of norepinephrine in three organs that were measured. Our studies with smaller doses of phentolamine have indicated a positive inotropic effect. In view of the findings of Dairman and his co-workers, it could reasonably be assumed that the inotropic effect results from increased production of catecholamines in the myocardium. This contention has received support from the recent work of Bagwell et al. (1970) . The decrease in the peripheral resistance led to a reflex increase in the cardiac output. The low dose of phentolamine (o03 mg/min) that we employed in our study produced no change in the systemic pressure or peripheral resistance. This was due to the predominant inotropic effect of the drug which masked phentolamine's vasodilating action. The negligible change in the cardiac output may at first appear paradoxical. This response has, however, been explained by Braunwald, Ross, and Sonnenblick (I967). They state that the contractile state of the myocardium is not the factor that limits the volume of blood ejected by the heart in the normal person, and that an improvement of myocardial contractility by a drug with a positive inotropic effect would not be expected to increase the output in a normal subject.
Phentolamine consistently lowers pressures in the pulmonary circulation, no matter what dose is employed (Gould et al., I969; Evans, Smulyan, and Eich, I967; Taylor et al., I965b). This effect, often accompanied by a fall in the pulmonary vascular resistance, has been considered evidence suggestive of pulmonary vasodilatation. The pulmonary blood volume was not determined in the study.
However, Taylor et al. (i965a) determined that the acute injection of phentolamine was followed by a fall in the pulmonary artery and left atrial pressures at a time when there was a considerable increase in pulmonary blood volume. They concluded that the drug caused a direct relaxation of the vascular smooth muscles of the pulmonary bed. This is the (Freis, MacKay, and Oliver, I95I) . The drug also has an obvious peripheral vasodilating effect which is not blocked by atropine (Goodman and Gilman, i955 Other hypotheses can be offered to explain the decline in the pulmonary artery pressure. Phentolamine by reducing airway obstruction could reduce endobronchial pressure and secondarily reduce pulmonary vascular pressures. None of our subjects had clinically evident bronchospasm, but it is not possible to exclude a direct mechanical effect on the pulmonary blood vessels mediated by bronchomotor activity. However, the comparable one-second forced expiratory volume obtained before and after phentolamine administration suggests that little change occurred in the airway obstruction. It has been shown that a reduction in hydrogen ion concentration is associated with pulmonary arteriolar dilatation in patients with chronic lung disease (Enson et al., I964) . In this study there was no correlation between the changes in arterial pH or PaCO2 and the reduction in pulmonary artery pressure. Phentolamine could reduce pulmonary artery pressure by increasing alveolar oxygen tension. It was shown in this study that phentolamine administration had a minimal effect on the PaO2 and the oxygen saturation.
Taylor et al. (I965a) cautioned against the use of the drug in reducing pulmonary hypertension, since in the dose they employed the decline in the systemic vascular resistance could be hazardous. However by using the low infusion rate of 0-3 mg/min this complication can be avoided.
This study suggests that the infusion of phentolamine at 0o3 mg/min may also be of benefit to patients with cor pulmonale. Further investigation of phentolamine's action in this condition is warranted. 
